TNF‐238 polymorphism may predict bronchopulmonary dysplasia among preterm infants in the Egyptian population

Abstract

The TNFα -238G > A polymorphism-particularly the presence of an A allele-should be evaluated as a biomarker to predict the clinical outcome of preterm infants with BPD in Egypt. Even the presence of one copy of this mutant allele appears to be sufficient to influence the severity of disease.